3 Although no studies have prospectively stratified patients by baseline A1C in evaluation of the A1C-lowering efficacy of a DPP-4 inhibitor or SGLT2 inhibitor, post-hoc subgroup analyses have shown that the efficacy of SGLT2 inhibitors is greater than that of DPP-4 inhibitors among patients with higher baseline A1C ( 8-8.5%), while patients with baseline A1C at the lower end of the spectrum ( 30 mL/min and clinical CV disease according to Diabetes Canada
Research Peptide
We hope to identify whether specific adjustments to our payment policies for SaaS technologies are needed to more accurately and appropriately pay for these products and services across settings of care
Notably, after 43 days of treatment, significant reductions in AUC were observed in all groups receiving GLP-1 receptor agonists, indicating improved glycemic control ( Figure S4B , D , Method S3 )
Portillo Canales presented her research on July 14 at ENDO 2025, the Endocrine Societys annual meeting in San Francisco, California
transdermal systems may additionally cause local skin reactions